Quarterly Report

ASHLAND INC. Filed 2026-07-29 Acc 0001193125-26-324226

Documents 1

2026-07-30 4 SVP and CTO acquired 1,267 shares (option exercise)
2026-07-29 10-Q Quarterly Report
2026-07-29 4 SVP and GM, Life Sciences acquired 3,215 shares (option exercise)
2026-07-28 8-K Material agreement · Executive or director change · Regulation FD disclosure
2026-07-28 8-K Results of operations · Regulation FD disclosure
2026-07-28 SCHEDULE 13G Statement of Beneficial Ownership
2026-04-29 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading ash-20260630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…